Method of increasing the relative number of CD34.sup.+ cells in a cell population
Patent Number: 6090625
Date of First Priority Issue: Thursday February 2nd, 1995
Date Issued: Tuesday July 18th, 2000
Assignee: Dhoot, Ghazi Jaswinder (London, GB)
Inventor: Abuljadayel, Ilham (London, GB)
From Class: Expansion
Comments: No comments
This patent teaches that by crosslinking various portions of MHC II on differentiated cells, the cells will dedifferentiate and increase the number of CD34 stem cells. This patent, if the data is reproducible, could revolutionize stem cell therapy. The company currently developing this patent is called TriStem.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.